Drug name (and genertic name, trade name) Dosages it comes in (include ratio calculations)Ways of administration Side effects and any other information! Of cefazolin ( Ancef )
Drug name
Generic name: cefazolin sodium
Common trade names: Ancef, Kefzol (and other regional brands)
Dosages it comes in (include ratio calculations)
Common vial strengths (powder for injection): 250 mg, 500 mg, 1 g (1000 mg), 2 g (2000 mg).
Basic conversions: 1 g = 1000 mg; 2 g = 2000 mg.
Example ratio/calculation (concentration after dilution):
1 g diluted in 50 mL → 1000 mg / 50 mL = 20 mg/mL.
1 g diluted in 100 mL → 1000 mg / 100 mL = 10 mg/mL.
2 g diluted in 100 mL → 2000 mg / 100 mL = 20 mg/mL.
500 mg diluted in 10 mL → 500 mg / 10 mL = 50 mg/mL.
Typical dosing ranges (general summaries, not patient-specific orders):
Adult infections: commonly 1–2 g IV every 8 hours depending on severity and indication.
Surgical prophylaxis: commonly 1–2 g IV as a single dose before incision (dose may be repeated for prolonged procedures or significant blood loss).
Pediatrics: commonly 25–50 mg/kg per dose IV every 8 hours (dose and interval vary by age and infection).
Renal impairment: dose and/or interval adjustments required (consult dosing references).
Ways of administration
Intravenous (IV) bolus or IV infusion (most common in hospital settings).
Intramuscular (IM) injection (less commonly used; can be painful).
Prepared as powder for reconstitution according to manufacturer instructions; then diluted in compatible IV fluids for infusion when indicated.
Not given orally—only parenteral formulations are available.
Side effects
Hypersensitivity reactions: rash, urticaria, anaphylaxis (cross-reactivity possible in some patients with penicillin allergy).
Gastrointestinal: diarrhea, nausea, vomiting; Clostridioides difficile–associated diarrhea is a potential serious complication.
Local reactions: pain or phlebitis at injection site (especially with IM or IV administration).
Hematologic: eosinophilia, neutropenia, thrombocytopenia (usually reversible).
Hepatic: transient elevations in liver enzymes.
Renal: rare nephrotoxicity; dose adjustments required in renal impairment to reduce risk of accumulation and CNS toxicity.
CNS: seizures reported rarely with very high doses or renal failure.
Other important information
Class and mechanism: first-generation cephalosporin antibiotic; bactericidal via inhibition of bacterial cell wall synthesis. Good activity against many gram-positive organisms (including MSSA and streptococci) and some gram-negative bacilli (e.g., E. coli, Proteus, Klebsiella).
Common clinical uses: surgical prophylaxis, skin and soft tissue infections, bone and joint infections, urinary tract infections (when susceptible), and bacteremia due to susceptible organisms.
Contraindications and precautions: known severe hypersensitivity to cefazolin or other cephalosporins; use caution in patients with a history of penicillin allergy. Adjust dosing in renal impairment and monitor renal function during prolonged therapy.
Pregnancy and lactation: commonly used in pregnancy when indicated; discuss with provider. Cefazolin is generally considered acceptable in pregnancy but follow local guidance.
Interactions and compatibility: check IV compatibility charts before mixing with other drugs/solutions; follow manufacturer guidance for reconstitution and diluent choice.
Monitoring: monitor for clinical response, signs of allergic reaction, C. difficile–related diarrhea, renal function, and complete blood count for prolonged therapy.
Storage and preparation: store and reconstitute per manufacturer labeling; use aseptic technique and discard unused reconstituted solution per guidance.
Tag: Nursing
-
Drug name (and genertic name, trade name) Dosages it comes in (include ratio calculations)Ways of…
-
What is the primary benefit of using deep tissue massage on tight muscles? Increased relaxation…
What is the primary benefit of using deep tissue massage on tight muscles?
Increased relaxation
Improved range of motion
Better skin elasticity
Release of chronic muscle tension -
uestion 28patient tells the nurse, “I’m becoming more and more sensitive to loud noises.” Which…
uestion 28patient tells the nurse, “I’m becoming more and more sensitive to loud noises.” Which ditory system change would the nurse suspect?BrainInner earMiddle earExternal ear
-
What does the acronym AIDS stand for?Red Cross aid programs for patients in AfricaAcquired…
What does the acronym AIDS stand for?
Red Cross aid programs for patients in Africa
Acquired immunodeficiency syndrome
Adult infectious disease syndrome
Auto immune disease syndrome -
Question 87 (1 point)What is the name of the structure produced by the nursing calf which causes…
Question 87 (1 point)
What is the name of the structure produced by the nursing calf which causes milk toby-pass the rumen, reticulum, and omasum?
esophageal groove -
Medicine tends to focus on thecare of individuals and families, whilepublic health focuses…
Medicine tends to focus on the care of individuals and families, while public health focuses on diagnostic; prevention; medical; promotion; clinical; populations; supportive communities
-
In some cases, low-dose amiodarone may be used to prevent recurrence of what cardiac…
In some cases, low-dose amiodarone may be used to prevent recurrence of what cardiac disorder?Angina PectorisAtrial FibrillationVentricular HypertrophyMitral Valve Regurgitation
Angina Pectoris
Atrial Fibrillation
Ventricular Hypertrophy
Mitral Valve Regurgitation -
Interventions incorporated in a plan of care areA. goal drivenB. designed to move the patient…
Interventions incorporated in a plan of care areA. goal drivenB. designed to move the patient toward full recoveryC. progressiveD. planned for 60 to 90 days
-
Ownership of the medical record resides with:Group of answer choicesthe provider (hospital, nursing…
Ownership of the medical record resides with:
Group of answer choices
the provider (hospital, nursing facility, etc.)
legal counsel
the patient
the physician rendering the treatment -
Outline the aspects to be considered in planning the provision of integrated sexual and…
Outline the aspects to be considered in planning the provision of integrated sexual and reproductive health service delivery under the strengthening an effective referral system
Policy and governance
Align referral planning with national and local SRH policies, laws and guidelines; define governance structures, roles and responsibilities across levels of care.
Stakeholder engagement and partnerships
Engage public, private, NGO and community actors; establish coordination mechanisms and agreements (MOUs) to support integrated referral pathways.
Service mapping and network design
Map available SRH services (facility capability, hours, catchment areas) and design referral networks to ensure appropriate, timely links between primary, secondary and specialized care.
Defined service package and referral criteria
Specify the integrated SRH services offered at each level and standardize clinical and non-clinical referral criteria and indication lists to guide providers.
Standard operating procedures and protocols
Develop and disseminate SOPs, referral forms, checklists and clinical algorithms to standardize assessment, referral decision-making, stabilization, transfer and feedback.
Referral communication and information systems
Establish reliable communication channels (phone, SMS, electronic referral systems) and data interoperability to track referrals, confirmations and outcomes.
Patient navigation and linkage mechanisms
Provide patient navigators, case managers or community health workers to support clients through the referral pathway and reduce loss to follow-up.
Transport and logistics
Plan for safe, timely transport options, cost coverage or vouchers, and clear procedures for emergency transfers and commodity movement.
Capacity building and workforce
Train providers on integrated SRH clinical care, referral protocols, communication, confidentiality, consent and culturally sensitive care; ensure ongoing supervision.
Supply chain and commodities
Ensure consistent availability of essential SRH commodities, diagnostics and equipment across referral network nodes to avoid interruptions in continuity of care.
Quality assurance and clinical governance
Implement quality standards, clinical audits, peer review and mechanisms to monitor adherence to referral and treatment protocols.
Monitoring, evaluation and indicators
Define core indicators (referral rates, timeliness, referral completion, outcomes, client satisfaction), collect data routinely and use it for performance improvement.
Client-centredness, confidentiality and consent
Respect clients’ rights, privacy and informed consent; design pathways that prioritize dignity, confidentiality, gender sensitivity and adolescent-friendly approaches.
Equity and accessibility
Address barriers for marginalized populations (cost, distance, language, disability, gender norms) and design targeted strategies to improve equitable access.
Community engagement and demand generation
Involve communities in planning, raise awareness about available integrated SRH services and referral options, and leverage community networks to support uptake.
Legal, ethical and cultural considerations
Ensure referrals comply with legal frameworks (e.g., age of consent), respect cultural contexts and address potential ethical dilemmas (confidential care for adolescents).
Financing and sustainability
Plan sustainable funding for referral functions (transport, communication, staffing), consider insurance schemes, user fee policies and budget lines for referral activities.
Feedback, continuity and follow-up
Establish mechanisms for receiving feedback from receiving facilities, ensuring continuity of care, documenting outcomes and arranging return/referral-back when needed.
Risk management and emergency preparedness
Include contingency plans for high-volume periods, epidemics or service disruptions, and ensure referral pathways function under emergencies.
Information privacy and data security
Implement safeguards for client health information within referral records and electronic systems to protect confidentiality and comply with data protection standards.
Performance review and continuous improvement
Regularly review referral performance, conduct after-action reviews, incorporate lessons learned and revise protocols and training accordingly.
Technology integration and innovation
Assess feasibility of e-referral platforms, telemedicine, mobile follow-up and digital registries to enhance coordination and tracking across the referral network.